<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FEDC2C7D-5094-4EC0-BD8F-115B7BCB6179"><gtr:id>FEDC2C7D-5094-4EC0-BD8F-115B7BCB6179</gtr:id><gtr:name>University of Florida</gtr:name><gtr:address><gtr:line1>University of Florida</gtr:line1><gtr:line4>Gainesville</gtr:line4><gtr:line5>Florida FL 32611</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Sir William Dunn Sch of Pathology</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FEDC2C7D-5094-4EC0-BD8F-115B7BCB6179"><gtr:id>FEDC2C7D-5094-4EC0-BD8F-115B7BCB6179</gtr:id><gtr:name>University of Florida</gtr:name><gtr:address><gtr:line1>University of Florida</gtr:line1><gtr:line4>Gainesville</gtr:line4><gtr:line5>Florida FL 32611</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/EFD541EC-F53F-4F79-BFA5-8DCE70466421"><gtr:id>EFD541EC-F53F-4F79-BFA5-8DCE70466421</gtr:id><gtr:firstName>A</gtr:firstName><gtr:otherNames>Neil</gtr:otherNames><gtr:surname>Barclay</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0500845"><gtr:id>C8EDDE64-C28C-425D-9968-FF8A0D2574AA</gtr:id><gtr:title>Intercellular membrane protein interactions - identification using protein microarrays and characterisation</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0500845</gtr:grantReference><gtr:abstractText>Communication between cells is an essential process in biology. For instance one gets very different types of response in terms of strength, duration and extent between a local pathogen infection with a cut and one that affects the whole body such is in influenza. These events are controlled through proteins at the surface of cells. If the response is not optimum then there is a potential for autoimmune disease or the failure to clear cancer cells. Interactions at the surface of these cells are crucial in obtaining the correct control. The same is true in other organs e.g. in brain to ensure the correct arrangement of neurons, and with blood cells to ensure they migrate properly through the blood vessels. The surfaces of these cell types contain hundreds of different proteins. Some of their interactions are known but many are not. This project aims to utilise newly established nanotechnology protein methods to identify and characterise these interactions on a systematic basis. Firstly a subset of proteins that are predicted on structural grounds to be likely to interact with other surface proteins will be selected and small amounts of protein made using recombinant DNA methods. These will be arrayed in a grid of several hundred small spots, with around 200 picogram (one million millionth of a gram) of each protein and tested for binding to possible ligands. The identification of the interactions is a first step in understanding their functions in biology. There is also a potential clinical benefit in that these interactions are possible therapeutic targets where regulation is not optimal, e.g. in enhancing responses against viruses and cancer cells, and in switching off responses in autoimmune diseases. The technology should be applicable to other areas such as in fertilisation namely in sperm egg interactions. 
I will continue to ensure that the results are published promptly and well detailed on the WWW. Medical benefits are likely to be in the long term but there is considerable interest in the technology and I will continue to ensure this is well publicised e.g. the new microarray technology was highlighted recently on the MRC WWW page (March 2005).</gtr:abstractText><gtr:technicalSummary>Interactions between proteins at the surface of opposing cells are vital for the cells to respond to their environments and this is particularly important for interactions of neurons, lymphocytes and other blood cells where failures lead to neurological and immune disorders. These interactions are often of low affinity and new interactions are difficult to identify and characterise. We wish to apply new high throughput protein microarray techniques that we have recently developed. It involves building and screening a library of extracellular domains of membrane proteins using protein microarrays. Once identified selected interactions will be studied in more detail at the biochemical and functional levels. The major lines of research are; 
1. The development of the new protein microarray assays. 
2. The design, cloning and production of a library of extracellular regions of membrane proteins from leukocytes, endothelium and neural cells.
3. The identification of ligands for membrane proteins such as families of CD200RL and SIRP genes. 
4. Evaluation of leads from (3) using quantitative biochemical analysis and functional analysis using antibodies and recombinant proteins
5. New areas of research for utilising the protein microarray library will be evaluated e.g. identifying specificity of autoantibodies, identifying receptors for viruses and bacteria.</gtr:technicalSummary><gtr:fund><gtr:end>2009-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>281986</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Florida</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Molecular Genetics and Microbiology</gtr:department><gtr:description>Interactions of viral proteins and the immune system</gtr:description><gtr:id>AAFECE09-867C-4FEA-9C7F-445566D67FA1</gtr:id><gtr:impact>PMID 19570854 I expect that the collaboratin will continue given funding.</gtr:impact><gtr:outcomeId>8C327346FFB-1</gtr:outcomeId><gtr:partnerContribution>Contribution in reagents and academically</gtr:partnerContribution><gtr:piContribution>We carried out biochemical analysis and also our expertise in the field of surface proteins on leukocytes</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Monoclonal antibodies have been made that recongise membrane proteins. They are vital for our research but we continue to make them widely available to the scientific community by direct distribution and through commercialisation.</gtr:description><gtr:id>52F860CF-CFB5-40D9-B6BA-9C2053C7A01A</gtr:id><gtr:impact>They allow proteins to be recognised. Equivalent reagents have not been produced by others</gtr:impact><gtr:outcomeId>3E0C409E1FF</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Monoclonal antibodies</gtr:title><gtr:type>Antibody</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We developed new ways to detect the weak protein interactions that are common for cell surface proteins but difficult to detect.</gtr:description><gtr:id>B45226CF-4813-4C12-B7D0-61541C8F3091</gtr:id><gtr:impact>We identified one particuarly interesting interaction and we and others are using the technique.</gtr:impact><gtr:outcomeId>F45210166BE</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Multivalent reagents to detect weak protein interactions</gtr:title><gtr:type>Data analysis technique</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>2FD7F1ED-6271-4092-98AF-BCE044A8B17D</gtr:id><gtr:title>Identification of leucocyte surface protein interactions by high-throughput screening with multivalent reagents.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92b50da26a80fd7153eb54402d918dff"><gtr:id>92b50da26a80fd7153eb54402d918dff</gtr:id><gtr:otherNames>Jiang L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>793DDFBED9A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>803BA60C-6C01-426B-82CD-A8BBFA500453</gtr:id><gtr:title>New assay to detect low-affinity interactions and characterization of leukocyte receptors for collagen including leukocyte-associated Ig-like receptor-1 (LAIR-1).</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92b50da26a80fd7153eb54402d918dff"><gtr:id>92b50da26a80fd7153eb54402d918dff</gtr:id><gtr:otherNames>Jiang L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>2F5A590450E</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0500845</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>